NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 193 filers reported holding NATERA INC in Q1 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,707,032 | +13.2% | 38,577 | +24.5% | 0.00% | 0.0% |
Q2 2023 | $1,507,925 | -52.3% | 30,989 | -45.6% | 0.00% | -50.0% |
Q1 2023 | $3,160,976 | +141.7% | 56,934 | +74.9% | 0.00% | +100.0% |
Q4 2022 | $1,307,895 | -100.0% | 32,559 | -57.2% | 0.00% | -50.0% |
Q2 2022 | $2,693,405,000 | -56.2% | 75,999 | -49.7% | 0.00% | -50.0% |
Q1 2022 | $6,144,144,000 | +2640.1% | 151,036 | +6190.5% | 0.01% | – |
Q4 2021 | $224,229,000 | -16.1% | 2,401 | +0.1% | 0.00% | – |
Q3 2021 | $267,345,000 | +83.5% | 2,399 | +87.0% | 0.00% | – |
Q2 2021 | $145,659,000 | -85.8% | 1,283 | -87.3% | 0.00% | -100.0% |
Q1 2021 | $1,023,117,000 | -96.0% | 10,076 | -96.0% | 0.00% | -97.9% |
Q4 2020 | $25,304,154,000 | +272.2% | 254,262 | +170.2% | 0.05% | +370.0% |
Q3 2020 | $6,798,795,000 | +97.3% | 94,114 | +36.2% | 0.01% | +66.7% |
Q2 2020 | $3,446,223,000 | -50.2% | 69,118 | -70.2% | 0.01% | -57.1% |
Q1 2020 | $6,923,340,000 | +6.5% | 231,860 | +20.2% | 0.01% | +16.7% |
Q4 2019 | $6,498,094,000 | +1849.2% | 192,879 | +1797.7% | 0.01% | +1100.0% |
Q3 2019 | $333,379,000 | +143.7% | 10,164 | +104.9% | 0.00% | – |
Q2 2019 | $136,797,000 | -16.0% | 4,960 | -37.2% | 0.00% | – |
Q1 2019 | $162,877,000 | +1269.4% | 7,899 | +827.1% | 0.00% | – |
Q4 2018 | $11,894,000 | -71.7% | 852 | -51.5% | 0.00% | – |
Q3 2018 | $42,039,000 | +32.2% | 1,756 | +3.9% | 0.00% | – |
Q2 2018 | $31,806,000 | -50.3% | 1,690 | -75.5% | 0.00% | – |
Q1 2018 | $64,028,000 | +6.9% | 6,907 | +3.7% | 0.00% | – |
Q4 2017 | $59,873,000 | +42.1% | 6,660 | +103.7% | 0.00% | – |
Q3 2017 | $42,137,000 | +13.1% | 3,269 | -4.7% | 0.00% | – |
Q2 2017 | $37,261,000 | +673.7% | 3,431 | +531.9% | 0.00% | – |
Q1 2017 | $4,816,000 | -51.5% | 543 | -36.0% | 0.00% | – |
Q4 2016 | $9,930,000 | -58.8% | 848 | -60.9% | 0.00% | – |
Q3 2016 | $24,098,000 | +95.3% | 2,169 | +112.0% | 0.00% | – |
Q2 2016 | $12,337,000 | -34.1% | 1,023 | -41.0% | 0.00% | – |
Q4 2015 | $18,728,000 | -7.0% | 1,734 | -6.6% | 0.00% | – |
Q3 2015 | $20,138,000 | – | 1,856 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |